EarningsQ2 2024 Earnings Report

Sarepta Therapeutics (AB3A) Q2 2024 Earnings Report

0 Followers

CH:AB3A Q2 2024 EPS Results

Actual EPSCHF0.06

Consensus EPS-CHF0.11

Beat/MissBeat by +CHF0.16

One Year Ago EPS-CHF0.22

Actual RevenueCHF299.00M

Expected RevenueCHF324.91M

Beat/MissMissed by -CHF25.91M

YoY Revenue Growth+38.93%

QuarterQ2 2024

Date08/07/2024

TimeAfter Close

Conference CallWednesday, August 7, 2024

CH:AB3A Upcoming Earnings

Sarepta Therapeutics's next earnings date is estimated for November 5, 2026, based on past reporting schedules.

CH:AB3A Q2 2024 Earnings Call

0:00 / 0:00

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 05, 2026	2026 (Q3)	0.06 / -	-1.483	―
Aug 05, 2026	2026 (Q2)	0.18 / -0.04	1.557	-102.65% (-1.60)
May 06, 2026	2026 (Q1)	0.80 / 2.37	-3.79	162.61% (+6.16)
Feb 25, 2026	2025 (Q4)	-0.99 / -3.24	1.236	-362.00% (-4.47)
Nov 03, 2025	2025 (Q3)	-0.60 / -1.48	0.28	-629.41% (-1.76)
Aug 06, 2025	2025 (Q2)	0.69 / 1.56	0.058	2600.00% (+1.50)
May 06, 2025	2025 (Q1)	-2.64 / -3.79	0.305	-1343.24% (-4.09)
Feb 26, 2025	2024 (Q4)	1.55 / 1.24	0.387	219.15% (+0.85)
Nov 06, 2024	2024 (Q3)	-0.06 / 0.28	-0.379	173.91% (+0.66)
Aug 07, 2024	2024 (Q2)	-0.11 / 0.06	-0.222	125.93% (+0.28)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed